 RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores 
              Glenmark Pharmaceuticals Ltd has announced that the subsidiary Glenmark Generics Ltd has, on September 30, 2009, filed the Draft Red Herring Prospectus (DRHP) with SEBI for an Initial Public Offer.
The Glenmark Pharmaceuticals stock closed the day at Rs.237.50, up by Rs.2.60 or 1.11%. The stock hit an intraday high of Rs.239.90 and low of Rs.234.50.
The total traded quantity was 763735 compared to 2 week average of 738887.